SYK and neoplasm: Most notably, we found that Syk inhibition did not reduce tumor growth in CD8-depleted mice suggesting that Syk inhibition reduces tumor growth by promoting immunostimulatory transcriptional programming in macrophages leading to the recruitment and activation of CD8+ T cells (Figure 4H).